ZA899948B - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
ZA899948B
ZA899948B ZA899948A ZA899948A ZA899948B ZA 899948 B ZA899948 B ZA 899948B ZA 899948 A ZA899948 A ZA 899948A ZA 899948 A ZA899948 A ZA 899948A ZA 899948 B ZA899948 B ZA 899948B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
ZA899948A
Other languages
English (en)
Inventor
Kurt Burghart
Burghart Kurt
Walter Burghart
Burghart Walter
Original Assignee
Burghart Kurt
Burghart Walter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Burghart Kurt, Burghart Walter filed Critical Burghart Kurt
Publication of ZA899948B publication Critical patent/ZA899948B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
ZA899948A 1988-12-30 1989-12-28 Pharmaceutical preparation ZA899948B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0321188A AT391269B (de) 1988-12-30 1988-12-30 Pharmazeutische zubereitung

Publications (1)

Publication Number Publication Date
ZA899948B true ZA899948B (en) 1990-09-26

Family

ID=3547077

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA899948A ZA899948B (en) 1988-12-30 1989-12-28 Pharmaceutical preparation

Country Status (11)

Country Link
US (1) US5196184A (pt)
EP (1) EP0376917B1 (pt)
JP (1) JP3034949B2 (pt)
AT (1) AT391269B (pt)
AU (1) AU630399B2 (pt)
CA (1) CA2006778C (pt)
DE (1) DE58905160D1 (pt)
DK (1) DK205590A (pt)
PT (1) PT92771B (pt)
WO (1) WO1990007345A1 (pt)
ZA (1) ZA899948B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4422881A1 (de) * 1993-10-25 1995-04-27 Bayer Ag Kolloidal dispergierbare Wirkstoff-Formulierungen
GB2285921A (en) * 1994-01-31 1995-08-02 Leilani Lea Sublingual administration of medicaments
HU214582B (hu) * 1994-07-26 1998-04-28 EGIS Gyógyszergyár Rt. Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására
KR100398713B1 (ko) * 1996-11-06 2004-02-05 주식회사 한국코러스제약 비페닐디메칠디카르복실레이트(ddb)제제
GB2368792A (en) * 2000-10-06 2002-05-15 Roger Randal Charles New Absorption enhancers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066697B (it) * 1976-11-08 1985-03-12 Manetti & Roberts Italo Brit Attivatore per composizioni cosmetiche e composizioni cosmetiche che lo contengono
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤
EP0175671A1 (de) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
EP0207638B1 (en) * 1985-06-04 1990-12-19 Teijin Limited Sustained-release pharmaceutical preparation
ATE71520T1 (de) * 1986-03-10 1992-02-15 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
JPS6351326A (ja) * 1986-08-22 1988-03-04 Nisshin Flour Milling Co Ltd ニコランジル外用剤
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US4804541A (en) * 1987-08-11 1989-02-14 Moleculon, Inc. Transdermal administration using benzyl alcohol

Also Published As

Publication number Publication date
WO1990007345A1 (de) 1990-07-12
CA2006778A1 (en) 1990-06-30
PT92771A (pt) 1990-06-29
DE58905160D1 (de) 1993-09-09
PT92771B (pt) 1996-01-31
CA2006778C (en) 2000-05-16
EP0376917A1 (de) 1990-07-04
US5196184A (en) 1993-03-23
AU630399B2 (en) 1992-10-29
EP0376917B1 (de) 1993-08-04
AU4758190A (en) 1990-08-01
ATA321188A (de) 1990-03-15
JP3034949B2 (ja) 2000-04-17
JPH03504727A (ja) 1991-10-17
DK205590D0 (da) 1990-08-28
AT391269B (de) 1990-09-10
DK205590A (da) 1990-10-01

Similar Documents

Publication Publication Date Title
GB8822857D0 (en) Pharmaceutical formulations
GB8610572D0 (en) Pharmaceutical preparation
ZA895838B (en) Pharmaceutical compounds
GB8924052D0 (en) Pharmaceutical solution
ZA89260B (en) Pharmaceutical compounds
ZA899948B (en) Pharmaceutical preparation
GB8721313D0 (en) Pharmaceutical preparation
GB8807505D0 (en) Pharmaceutical combinations
GB8830405D0 (en) Pharmaceutical formulation
GB8817575D0 (en) Pharmaceutical preparation
GB8921595D0 (en) Pharmaceutical preparation
EG18240A (en) New pharmaceutical preparation
GB8805076D0 (en) Pharmaceutical combinations
GB8805077D0 (en) Pharmaceutical combinations
GB8808838D0 (en) Pharmaceutical combinations
IE882467L (en) Pharmaceutical preparation for external use
GB8828994D0 (en) Pharmaceutical formulations
GB8820271D0 (en) Pharmaceutical formulations
GB8816609D0 (en) Pharmaceutical formulations
GB8810733D0 (en) Pharmaceutical formulations
GB8820175D0 (en) Pharmaceutical formulations
IE882439L (en) Pharmaceutical formulations
GB8804790D0 (en) Pharmaceutical formulations
GB8820272D0 (en) Pharmaceutical formulations
GB8820273D0 (en) Pharmaceutical formulations